2
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Leukemia
8
Sarcoma
5
Neoplasms
4
Colorectal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Breast Neoplasms
3
Unspecified Adult Solid Tumor, Protocol Specific
2
Triple Negative Breast Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Melanoma
2
Lymphoma, Large B-Cell, Diffuse
2
Leukemia, Myelomonocytic, Acute
2
Leukemia, Myeloid, Acute
2
Leukemia, Monocytic, Acute
2
Leukemia, Megakaryoblastic, Acute
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia, Erythroblastic, Acute
2
Head and Neck Neoplasms
2
Endometrial Neoplasms
2
Congenital Abnormalities
2
Cholangiocarcinoma
2
Biliary Tract Neoplasms
2
Wilms Tumor
1
Waldenstrom Macroglobulinemia
1
Toxoplasmosis
1
Thrombocytosis
1
Testicular Neoplasms
1
Testicular Germ Cell Tumor
1
Recurrence
1
Rectal Neoplasms
1
Interventions
Carboplatin
71
Paclitaxel
49
Radiotherapy
44
Pemetrexed
42
Cisplatin
41
Bevacizumab
39
Gemcitabine
27
Docetaxel
27
Erlotinib Hydrochloride
23
Gefitinib
18
pembrolizumab
14
Taxes
13
Vinorelbine
10
Cetuximab
10
Radiation
8
Nivolumab
8
Magnetic Resonance Spectroscopy
8
capmatinib
7
Radiosurgery
7
Platinum
7
Etoposide
7
Surgical Procedures, Operative
6
Radiotherapy, Conformal
6
Mastectomy, Segmental
6
ceritinib
5
aflutinib
5
Specimen Handling
5
Neoadjuvant Therapy
5
Cyclophosphamide
5
Biopsy
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Adenocarcinoma of Lung
×
Base Sequence
×
Clear all
NCT02843711
2016-07-26
LUNG-EST
Hospices Civils de Lyon
Unknown
152 enrolled